Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 28, 2014

View Archived Issues

Researchers present novel radiomitigating compounds

Nuvilex forms consortium to oversee development of treatment for type 1 diabetes

Janssen and Transposagen to collaborate on allogeneic CAR T-cell therapies

Thermo Fisher Scientific and Samsung Electronics initiate POC diagnostic collaboration

Santhera and PPMD collaborate on risk/benefit analysis of idebenone as DMD respiratory therapy

Sevion enters into chimerasome research agreement with Avidity NanoMedicines

ACC inhibitors reported in Nimbus Discovery patent

First in vitro and in vivo data for DNA-PK and mTOR kinase dual inhibitor CC-115

Human tolerability and new preclinical data presented for ShK-186

PEGylated H-NOX protein may enhance radiotherapy for glioblastoma

Recombinant human placental growth factor as promising therapy for artherosclerosis

Project targeting CD73 supported by AmorChem and Univalor

Phase I results presented for AZD-7451 in adults with recurrent glioblastoma multiforme

Tonix Pharmaceuticals initiates ascending-dose phase I trial of oral TNX-201

FDA accepts for review Dysport sBLA for upper limb spasticity

Lilly patent describes prostanoid EP4 receptor antagonists

EZH2 inhibitors prepared and tested at GlaxoSmithKline

Novartis starts recruitment of patients with Sjogren's syndrome for phase II trial of CFZ-533

Takeda synthesizes PKC theta inhibitors

Chinese team divulges HGFR/VEGFR inhibitors for cancer

Kyowa Hakko Kirin to launch pegfilgrastim in Japan

Novartis applies for approval of vildagliptin/metformin combination tablets in Japan

First-in-human data for the anti-IL-13 antibody RPC-4046

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...